tiprankstipranks
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1
Holding DE:17Q1?
Track your performance easily

Pharmaron Beijing Co., Ltd. Class H (17Q1) Financial Statements

0 Followers

Pharmaron Beijing Co., Ltd. Class H Financial Overview

Pharmaron Beijing Co., Ltd. Class H's market cap is currently ―. The company's EPS TTM is €0.135; its P/E ratio is 12.36; and it has a dividend yield of 1.52%. Pharmaron Beijing Co., Ltd. Class H is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is €0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 2.86B¥ 2.77B¥ 2.53B¥ 2.10B¥ 2.14B
Gross Profit¥ 1.07B¥ 1.08B¥ 927.00M¥ 695.63M¥ 740.37M
EBIT¥ 501.66M¥ 508.11M¥ 468.20M¥ 355.73M¥ 742.66M
EBITDA¥ 501.66M¥ 508.11M¥ 468.20M¥ 355.73M¥ 742.66M
Net Income Common Stockholders¥ 413.50M¥ 375.67M¥ 336.35M¥ 249.09M¥ 620.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 2.24B¥ 2.74B¥ 3.45B¥ 4.35B¥ 5.10B
Total Assets¥ 20.49B¥ 19.71B¥ 18.97B¥ 18.66B¥ 18.39B
Total Debt¥ 6.12B¥ 5.71B¥ 5.45B¥ 5.40B¥ 5.29B
Net Debt¥ 3.87B¥ 2.97B¥ 2.00B¥ 1.05B¥ 186.68M
Total Liabilities¥ 9.65B¥ 9.17B¥ 8.68B¥ 8.32B¥ 8.09B
Stockholders Equity¥ 10.55B¥ 10.40B¥ 10.16B¥ 10.20B¥ 10.13B
Cash Flow-
Free Cash Flow¥ -2.95M¥ -348.67M¥ -199.90M¥ -255.52M¥ 97.58M
Operating Cash Flow-----
Investing Cash Flow¥ -924.69M¥ -1.23B¥ 367.86M¥ -424.83M¥ -906.56M
Financing Cash Flow¥ -143.19M¥ -206.82M¥ -769.15M¥ -298.11M¥ -148.38M
Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History

Pharmaron Beijing Co., Ltd. Class H Debt to Assets

Pharmaron Beijing Co., Ltd. Class H Cash Flow

Pharmaron Beijing Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis